Letter in reply: network meta-analysis for indirect comparison of lanadelumab and for the treatment of hereditary angioedema

Summary

We appreciate the comments from the authors of the Letter to the Editor regarding our recent publication “Network meta-analysis for indirect comparison of lanadelumab and berotralstat for the treatment of hereditary angioedema” [1] and welcome the opportunity to respond to the points raised.